RELISTOR may help relieve opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain (CNCP) or advanced illness (AI)1
PAMORA=peripherally acting mu-opioid receptor antagonist;
SBM=spontaneous bowel movement.
Limitations of Use: Use beyond four months has not been studied in the advanced illness population.
To report SUSPECTED ADVERSE REACTIONS, contact Salix at 1-800-508-0024 or FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch/
Please click here for full Prescribing Information for RELISTOR tablets and RELISTOR injection.